← Open Payments lookup

NAFEEZA ALLI: Open Payments

NPI 1588264246 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,023 in 230 payments from 19 companies in 2025. Trend: 2023 $4,113 · 2024 $3,950 · 2025 $5,023

Food & beverage: $5,023
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.23$629
Axsome Therapeutics, Inc.17$527
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$468
Teva Pharmaceuticals USA, Inc.26$415
Otsuka America Pharmaceutical, Inc.17$405
ABBVIE INC.22$379
Takeda Pharmaceuticals U.S.A., Inc.18$352
Vanda Pharmaceuticals Inc.11$324
Bausch Health US, LLC14$313
Indivior Inc.9$248

Products named: INGREZZA, Auvelity, CAPLYTA, REXULTI, VRAYLAR, TRINTELLIX, AUSTEDO XR, APLENZIN.

Industry payments across FL — which companies pay providers there.